We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+10.69%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$377M
AUM Growth
+$38.3M
Cap. Flow
+$4.65M
Cap. Flow %
1.23%
Top 10 Hldgs %
27.08%
Holding
117
New
3
Increased
49
Reduced
25
Closed
3

Top Sells

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$516K
2
MSFT icon
Microsoft
MSFT
+$494K
3
MDT icon
Medtronic
MDT
+$489K
4
HYD icon
VanEck High Yield Muni ETF
HYD
+$446K
5
VZ icon
Verizon
VZ
+$318K

Sector Composition

Rank Sector Weight
1 Technology 14.86%
2 Healthcare 13.19%
3 Consumer Staples 10.73%
4 Industrials 10.66%
5 Consumer Discretionary 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LH icon
26
Labcorp
LH
$25B
$5.48M 1.46%
24,129
+1,151
+5% +$242K
CVS icon
27
CVS Health
CVS
$133B
$5.32M 1.41%
67,433
+2,410
+4% +$172K
AMZN icon
28
Amazon
AMZN
$2.92T
$5.29M 1.4%
34,791
+360
+1% +$50.5K
PEP icon
29
PepsiCo
PEP
$190B
$5.28M 1.4%
31,076
+1,866
+6% +$309K
SNA icon
30
Snap-on
SNA
$21.2B
$5.25M 1.39%
18,183
+223
+1% +$60.2K
IEMG icon
31
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$5.15M 1.37%
101,898
+3,306
+3% +$160K
CL icon
32
Colgate-Palmolive
CL
$73.1B
$5.1M 1.35%
64,006
+2,075
+3% +$156K
XOM icon
33
ExxonMobil
XOM
$644B
$5.04M 1.34%
50,422
+1,416
+3% +$149K
BNY
34
Bank of New York Mellon
BNY
$106B
$4.9M 1.3%
94,146
+3,065
+3% +$141K
LMT icon
35
Lockheed Martin
LMT
$134B
$4.87M 1.29%
10,751
+295
+3% +$131K
TMO icon
36
Thermo Fisher Scientific
TMO
$213B
$4.71M 1.25%
8,872
+434
+5% +$210K
IEFA icon
37
iShares Core MSCI EAFE ETF
IEFA
$190B
$4.7M 1.25%
66,857
+1,607
+2% +$106K
KO icon
38
Coca-Cola
KO
$377B
$4.7M 1.25%
79,700
+2,330
+3% +$132K
OMC icon
39
Omnicom Group
OMC
$21.6B
$4.37M 1.16%
50,523
+610
+1% +$48.1K
SYY icon
40
Sysco
SYY
$40.8B
$4.3M 1.14%
58,840
+50
+0.1% +$3.45K
DUK icon
41
Duke Energy
DUK
$97.8B
$4.28M 1.14%
44,097
+3,022
+7% +$275K
IWM icon
42
iShares Russell 2000 ETF
IWM
$79.8B
$4.23M 1.12%
21,058
NEE icon
43
NextEra Energy
NEE
$181B
$4.14M 1.1%
68,222
+3,002
+5% +$171K
DIS icon
44
Walt Disney
DIS
$167B
$4.11M 1.09%
45,487
+2,287
+5% +$202K
XLE icon
45
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$3.94M 1.05%
94,082
+1,600
+2% +$68.4K
MDT icon
46
Medtronic
MDT
$109B
$3.88M 1.03%
47,096
-6,419
-12% -$489K
QRVO icon
47
Qorvo
QRVO
$7.99B
$3.81M 1.01%
33,850
+3,579
+12% +$346K
USB icon
48
US Bancorp
USB
$98.2B
$3.72M 0.99%
85,896
+5,197
+6% +$190K
VZ icon
49
Verizon
VZ
$195B
$3.68M 0.98%
97,576
-8,995
-8% -$318K
COP icon
50
ConocoPhillips
COP
$147B
$3.46M 0.92%
29,839
+678
+2% +$79.3K

Similar funds

Boston Research & Management's Q4 2023 Portfolio in Review

As of Q4 2023, Boston Research & Management held 117 positions worth $377M, up 11% from $338M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Research & Management's Q4 2023 filing shows 3 new, 49 increased, 25 reduced and 3 closed positions. Its largest new stake was General Dynamics: 840 shares worth $218K. The largest sale was Fastenal, an estimated $516K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Boston Research & Management's largest Q4 2023 buy was General Dynamics: 840 shares worth $218K.
  • Boston Research & Management added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2023, an estimated $926K increase.
  • Boston Research & Management's biggest Q4 2023 reduction was Fastenal, cutting an estimated $516K.
  • Boston Research & Management fully exited Yum China in Q4 2023, selling an estimated $240K.
  • Boston Research & Management's ten largest holdings make up 27% of its $377M portfolio in Q4 2023.
  • Boston Research & Management opened 3 new positions and closed 3 in Q4 2023.
  • Boston Research & Management's portfolio value rose 11% quarter-over-quarter to $377M.

Based on Boston Research & Management's 13F filing for Q4 2023, filed 12 Feb 2024.